Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD)
as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the …

Neuroenhancement is a pharmacological attempt to increase cognitive performance in
healthy humans. Strategies to improve learning and memory aim at plasticity pathways in the …

Therapeutic sleep deprivation (SD) is a rapid acting treatment for major depressive disorder
(MDD). Within hours, SD leads to a dramatic decrease in depressive symptoms in 50–60% …

It is unclear how binding of antidepressant drugs to their targets gives rise to the clinical
antidepressant effect. We discovered that the transmembrane domain of tyrosine kinase receptor …

BACKGROUND: Long-term synaptic plasticity is a ubiquitous form of neuronal plasticity that
regulates the strength of synaptic transmission in many brain areas. However, most data on …

BACKGROUND: A growing body of evidence suggests a disturbance of brain plasticity in
major depression. In contrast to hippocampal neurogenesis, much less is known about the role …

Major depressive disorder is among the most commonly diagnosed disabling mental
diseases. Several non-pharmacological treatments of depression upregulate adenosine …

BACKGROUND: The neuroplasticity hypothesis of depression proposes that a dysfunction
of neural plasticity—the basic ability of living organisms to adapt their neural function and …

Sleep is ubiquitous in animals and humans, but its function remains to be further determined.
The synaptic homeostasis hypothesis of sleep–wake regulation proposes a homeostatic …

Background: Platelets store large amounts of serotonin that they release during thrombus
formation or acute inflammation. This facilitates hemostasis and modulates the inflammatory …